Maria (Masha) Babak
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Maria (Masha) Babak
Jun 17, 2024, 17:50 |
Blog
Maria (Masha) Babak: In war-torn areas, cancer patients face a devastating reality
Maria (Masha) Babak shared a post by CityU iGEM on LinkedIn: "In war-torn areas, cancer…
Jun 7, 2024, 09:25 |
Blog
We are grateful to the University Grants Committee and Lingnan University for organizing the RGC Forum - The Babak Lab
The Babak Lab shared a post on LinkedIn: “Maria (Masha) Babak, PhD and our whole team…
May 30, 2024, 16:53 |
Positive
Anna Spreafico and Maria Babak Receive 2024 Yvonne Award in the Mentorship Category
Yvonne Award Winners 2024 by OncoDaily We are excited to announce the esteemed winners of…
May 28, 2024, 05:22 |
Opinion
Maria (Masha) Babak: The HECTOR deep learning model holds immense promise in improving personalized treatment strategies
Maria (Masha) Babak shared a post by The Babak Lab on LinkedIn: “Don't miss out on this groundbreaking…
May 27, 2024, 02:29 |
Blog
Jemma Arakelyan: Congratulations, Maria (Masha) Babak, PhD !!! Your mentorship is making a lasting impact
Jemma Arakelyan shared a post by OncoDaily, on LinkedIn: "Congratulations to my mentor Maria (Masha) Babak,…
Mar 19, 2024, 23:51 |
Blog
Maria (Masha) Babak: Another important figure we should celebrate this Women's History Month is Dr. Mary Claire King
Maria (Masha) Babak, Assistant Professor at City University of Hong Kong, shared on LinkedIn: “Another…
Feb 15, 2024, 11:36 |
Drugs
Maria (Masha) Babak: The results from the very first clinical trial in which I had the privilege to directly participate
Maria (Masha) Babak, Assistant Professor at City University of Hong Kong, shared a post by…
All:
7
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube